Status:
COMPLETED
Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Cervical Neoplasia
Eligibility:
FEMALE
21-100 years
Brief Summary
Background: * In most women, HPV infection does not cause symptoms and the infection goes away on its own. In a small percentage of women, the HPV infection does not go away and sometimes can result ...
Detailed Description
The carcinogenicity of the 15 HPV types with carcinogenic potential varies greatly. We wish to clarify clinical utility of carcinogenic HPV DNA testing in women 21 and older by understanding the uniqu...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Women in KPNC aged 25 years or older who tested positive for HPV.
- Will also include a random sample of women who tested negative for HPV.
- EXCLUSION CRITERIA:
- Male.
- Children under 18.
Exclusion
Key Trial Info
Start Date :
January 29 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2020
Estimated Enrollment :
131110 Patients enrolled
Trial Details
Trial ID
NCT00435214
Start Date
January 29 2007
End Date
April 30 2020
Last Update
May 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Northern California
Oakland, California, United States, 94612